Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors.

Koeppel F, Bobard A, Lefebvre C, Pedrero M, Deloger M, Boursin Y, Richon C, Chen-Min-Tao R, Robert G, Meurice G, Rouleau E, Michiels S, Massard C, Scoazec JY, Solary E, Soria JC, André F, Lacroix L.

Cancer J. 2018 Jul/Aug;24(4):153-162. doi: 10.1097/PPO.0000000000000322.

PMID:
30119077
2.

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.

Massard C, Michiels S, Ferté C, Le Deley MC, Lacroix L, Hollebecque A, Verlingue L, Ileana E, Rosellini S, Ammari S, Ngo-Camus M, Bahleda R, Gazzah A, Varga A, Postel-Vinay S, Loriot Y, Even C, Breuskin I, Auger N, Job B, De Baere T, Deschamps F, Vielh P, Scoazec JY, Lazar V, Richon C, Ribrag V, Deutsch E, Angevin E, Vassal G, Eggermont A, André F, Soria JC.

Cancer Discov. 2017 Jun;7(6):586-595. doi: 10.1158/2159-8290.CD-16-1396. Epub 2017 Apr 1.

3.

Correction of the FSHD myoblast differentiation defect by fusion with healthy myoblasts.

Dib C, Bou Saada Y, Dmitriev P, Richon C, Dessen P, Laoudj-Chenivesse D, Carnac G, Lipinski M, Vassetzky YS.

J Cell Physiol. 2016 Jan;231(1):62-71. doi: 10.1002/jcp.25110.

PMID:
26218298
4.

Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.

Truffaux N, Philippe C, Paulsson J, Andreiuolo F, Guerrini-Rousseau L, Cornilleau G, Le Dret L, Richon C, Lacroix L, Puget S, Geoerger B, Vassal G, Östman A, Grill J.

Neuro Oncol. 2015 Jul;17(7):953-64. doi: 10.1093/neuonc/nou330. Epub 2014 Dec 21.

5.

ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy.

Messai Y, Noman MZ, Hasmim M, Janji B, Tittarelli A, Boutet M, Baud V, Viry E, Billot K, Nanbakhsh A, Ben Safta T, Richon C, Ferlicot S, Donnadieu E, Couve S, Gardie B, Orlanducci F, Albiges L, Thiery J, Olive D, Escudier B, Chouaib S.

Cancer Res. 2014 Dec 1;74(23):6820-32. doi: 10.1158/0008-5472.CAN-14-0303. Epub 2014 Oct 8.

6.

Gene copy number variations in breast cancer of Sub-Saharan African women.

Ly M, Valent A, Diallo G, Penault-Lorca F, Dumke K, Marty V, Viehl P, Lazar V, Job B, Richon C, Scott V, Diallo DA, Bernaudin JF, Andre F.

Breast. 2013 Jun;22(3):295-300. doi: 10.1016/j.breast.2012.07.010. Epub 2012 Sep 19.

PMID:
22999459
7.

Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer.

Arnedos M, Scott V, Job B, De La Cruz J, Commo F, Mathieu MC, Wolp-Diniz R, Richon C, Campone M, Bachelot T, Dalenc F, Dessen P, Lacroix L, Lazar V, Soria JC, Delaloge S, Andre F.

Eur J Cancer. 2012 Oct;48(15):2293-9. doi: 10.1016/j.ejca.2012.06.014. Epub 2012 Jul 26.

PMID:
22840369
8.

Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.

Puget S, Philippe C, Bax DA, Job B, Varlet P, Junier MP, Andreiuolo F, Carvalho D, Reis R, Guerrini-Rousseau L, Roujeau T, Dessen P, Richon C, Lazar V, Le Teuff G, Sainte-Rose C, Geoerger B, Vassal G, Jones C, Grill J.

PLoS One. 2012;7(2):e30313. doi: 10.1371/journal.pone.0030313. Epub 2012 Feb 28.

9.

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.

Gattolliat CH, Thomas L, Ciafrè SA, Meurice G, Le Teuff G, Job B, Richon C, Combaret V, Dessen P, Valteau-Couanet D, May E, Busson P, Douc-Rasy S, Bénard J.

Br J Cancer. 2011 Oct 25;105(9):1352-61. doi: 10.1038/bjc.2011.388. Epub 2011 Oct 4.

10.

Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.

Itzhar N, Dessen P, Toujani S, Auger N, Preudhomme C, Richon C, Lazar V, Saada V, Bennaceur A, Bourhis JH, de Botton S, Bernheim A.

PLoS One. 2011 Feb 14;6(2):e16623. doi: 10.1371/journal.pone.0016623.

11.

hSMG-1 is a granzyme B-associated stress-responsive protein kinase.

Meslin F, Hamaï A, Mlecnik B, Rosselli F, Richon C, Jalil A, Wemhoff G, Thiery J, Galon J, Chouaib S.

J Mol Med (Berl). 2011 Apr;89(4):411-21. doi: 10.1007/s00109-010-0708-0. Epub 2011 Feb 8.

PMID:
21301799
12.

High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma.

Toujani S, Dessen P, Ithzar N, Danglot G, Richon C, Vassetzky Y, Robert T, Lazar V, Bosq J, Da Costa L, Pérot C, Ribrag V, Patte C, Wiels J, Bernheim A.

PLoS One. 2009 Sep 17;4(9):e7089. doi: 10.1371/journal.pone.0007089.

13.

Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines.

Olaussen KA, Commo F, Tailler M, Lacroix L, Vitale I, Raza SQ, Richon C, Dessen P, Lazar V, Soria JC, Kroemer G.

Oncogene. 2009 Dec 3;28(48):4249-60. doi: 10.1038/onc.2009.277. Epub 2009 Sep 14.

PMID:
19749798
14.

The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis.

Noman MZ, Buart S, Van Pelt J, Richon C, Hasmim M, Leleu N, Suchorska WM, Jalil A, Lecluse Y, El Hage F, Giuliani M, Pichon C, Azzarone B, Mazure N, Romero P, Mami-Chouaib F, Chouaib S.

J Immunol. 2009 Mar 15;182(6):3510-21. doi: 10.4049/jimmunol.0800854.

15.

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C, Richon C, Yan K, Wang B, Vassal G, Delaloge S, Hortobagyi GN, Symmans WF, Lazar V, Pusztai L.

Clin Cancer Res. 2009 Jan 15;15(2):441-51. doi: 10.1158/1078-0432.CCR-08-1791.

16.

Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.

Le Maux Chansac B, Missé D, Richon C, Vergnon I, Kubin M, Soria JC, Moretta A, Chouaib S, Mami-Chouaib F.

Int Immunol. 2008 Jul;20(7):801-10. doi: 10.1093/intimm/dxn038. Epub 2008 Apr 25.

PMID:
18441340
17.

Intragenic breakpoints localized by array CGH in a t(2;6) familial translocation.

Bernheim A, Toujani S, Guillaud-Bataille M, Richon C, Waxin H, Dessen P, Berger R.

Cytogenet Genome Res. 2007;119(3-4):185-90. doi: 10.1159/000112059. Epub 2008 Feb 1.

PMID:
18253027
18.

p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-alpha and melphalan.

Muret J, Yacoub M, Terrier P, Drusch F, Laplanche A, Gaudin C, Richon C, Le Péchoux C, Le Cesne A, Lejeune FJ, Tursz T, Fouret P, Bonvalot S, Chouaib S.

Ann Oncol. 2008 Apr;19(4):793-800. Epub 2007 Dec 6.

PMID:
18065405
19.

Granzyme B-induced cell death involves induction of p53 tumor suppressor gene and its activation in tumor target cells.

Meslin F, Thiery J, Richon C, Jalil A, Chouaib S.

J Biol Chem. 2007 Nov 9;282(45):32991-9. Epub 2007 Sep 13.

20.

Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death.

Friedlein G, El Hage F, Vergnon I, Richon C, Saulnier P, Lécluse Y, Caignard A, Boumsell L, Bismuth G, Chouaib S, Mami-Chouaib F.

J Immunol. 2007 Jun 1;178(11):6821-7.

21.

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.

Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.

Oncogene. 2006 Dec 7;25(58):7618-34. Epub 2006 Sep 18. Erratum in: Oncogene. 2007 Feb 22;26(8):1256.

PMID:
16983347
22.

The decreased susceptibility of metastatic melanoma cells to killing involves an alteration of CTL reactivity.

Gassara A, Messai Y, Gaudin C, Abouzahr S, Jalil A, Diarra-Mehrpour M, Faure F, Richon C, Avril MF, Even J, Chouaib S.

Int J Oncol. 2006 Jul;29(1):155-61.

PMID:
16773195
23.

Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure.

Abouzahr S, Bismuth G, Gaudin C, Caroll O, Van Endert P, Jalil A, Dausset J, Vergnon I, Richon C, Kauffmann A, Galon J, Raposo G, Mami-Chouaib F, Chouaib S.

Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1428-33. Epub 2006 Jan 23.

24.

p53 potentiation of tumor cell susceptibility to CTL involves Fas and mitochondrial pathways.

Thiery J, Abouzahr S, Dorothee G, Jalil A, Richon C, Vergnon I, Mami-Chouaib F, Chouaib S.

J Immunol. 2005 Jan 15;174(2):871-8.

25.

[Tumor/cytotoxic effector cross-talk in the control of tumor susceptibility to lysis].

Gati A, Dorothée G, Thiéry J, Guerra N, Richon C, Gaudin C, Mami-Chouaib F, Caignard A, Diarra-Mehrpour M, Chouaib S.

Bull Cancer. 2003 Aug-Sep;90(8-9):686-94. French.

26.

Potentiation of a tumor cell susceptibility to autologous CTL killing by restoration of wild-type p53 function.

Thiery J, Dorothée G, Haddada H, Echchakir H, Richon C, Stancou R, Vergnon I, Benard J, Mami-Chouaib F, Chouaib S.

J Immunol. 2003 Jun 15;170(12):5919-26.

27.

[Critical review of 25 patients treated for pubic pain with inguinal myorrhaphy (Nesovic operation)].

Fournier JY, Richon CA.

Helv Chir Acta. 1993 Jun;59(5-6):775-8. French.

PMID:
8376140
28.

Retroperitoneal silicosis mimicking pancreatic carcinoma in an Alpine miner with chronic lung silicosis.

Tschopp JM, Rossini MJ, Richon CA, Letovanec N, Joris F, Frey JG, Kaelin RM.

Thorax. 1992 Jun;47(6):480-1.

29.

[Hang-gliding accidents].

Andenmatten R, de Preux J, Richon CA.

Z Unfallchir Versicherungsmed Berufskr. 1989;82(3):198. French. No abstract available.

PMID:
2513694
30.

[Skiing accidents. Apropos of 1028 consecutive cases].

Fournier D, M'Baya A, Otten P, Richon CA.

Schweiz Rundsch Med Prax. 1987 Dec 1;76(49):1367-71. French. No abstract available.

PMID:
3423551
31.

[Our surgical experience with mountain injuries in 1978 and 1979].

Richon CA.

Z Unfallmed Berufskr. 1981;74(1-2):27-8. French. No abstract available.

PMID:
7303960
32.

[A case of intercostal hernia in a patient with mixed respiratory insufficiency].

Bettler S, Richon CA.

Rev Med Suisse Romande. 1980 May;100(5):443-5. French. No abstract available.

PMID:
7455470
33.

[Stenosis of the small intestine of ischemic origin in the adult (segmental and transmural lesions)].

Saegesser F, Borgeaud J, Schnyder P, Tabrizian M, Richon CA.

Schweiz Med Wochenschr. 1976 Mar 13;106(11):367-76. French.

PMID:
1251154
34.

Stenosis of the small intestine of ischemic origin.

Saegesser F, Borgeaud J, Schnyder P, Tabrizian M, Richon CA.

Helv Chir Acta. 1976 Mar;43(1-2):115-8. French. No abstract available.

PMID:
1270280
35.

[The prevention of postoperative delirium tremens (author's transl)].

Richon CA, Deslarzes C, Fornerod A.

Schweiz Rundsch Med Prax. 1976 Jan 13;65(2):57-9. French. No abstract available.

PMID:
1257200
36.

[An unusual case of covert gastric perforation].

Chapuis JM, Lathion G, Richon CA.

Rev Med Suisse Romande. 1972 Dec;92(12):951-7. French. No abstract available.

PMID:
4665192
37.

[Post-traumatic ischemic cicatricial stenosis of the jejunum].

Richon CA, Crespo A.

Rev Med Suisse Romande. 1972 Dec;92(12):945-50. French. No abstract available.

PMID:
4665191
38.

[A case of posttraumatic segmentary ischemic enteritis].

Richon CA, Crespo A.

Helv Chir Acta. 1972 May;39(1):127-8. French. No abstract available.

PMID:
5034255
39.

[Apropos of the treatment of elderly accident victims].

Richon CA.

Rev Med Suisse Romande. 1967 Jan;87(1):71-7. French. No abstract available.

PMID:
5595408
40.

[Fat embolism, a frequently misunderstood disorder].

ZANDER E, RICHON CA.

Schweiz Med Wochenschr. 1962 Dec 1;92:1561-5. French. No abstract available.

PMID:
14003190

Supplemental Content

Loading ...
Support Center